Omega Therapeutics taps Sawhney as CFO

Omega Therapeutics, a genomic medicine company, has named Dr. Roger Sawhney as chief financial officer.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this